Shares of Anupam Rasayan India Limited opened its trading session at Rs 1,205 and currently trade at Rs 1,184. The scrip is down 2.3 percent as compared to the previous closing price of Rs 1,212.05.
In the last 5 trading sessions, the stock has gained around 6 percent ranging from Rs 1,118 to the current levels. The stock hit its 52-week high mark yesterday and the same was recorded at a price of Rs 1,224.20.
Keeping a purview of 3 months, i.e., from February 2023 till date, the stock has been successful in delivering multibagger returns of approximately 104 percent which means that if someone would have invested Rs 1,00,000 in the stock, it would have converted to Rs 2,04,000 within a period of just 3 months.
In addition to the above, Anupam Rasayan announced its results for FY22-23 wherein it reported decent growth as far as the operating revenues and Profit After Tax (PAT) numbers are concerned. On a quarterly basis, the operating revenues jumped from Rs 392 crores in Q3 v/s Rs 480 crores in Q4, and the PAT figures, during the same period, increased from Rs 54 crores to Rs 73 crores.
Having a YoY comparison of the above-mentioned metrics, the operating revenues moved from Rs 1,074 crores during FY21-22 to Rs 1,602 crores in FY22-23. Moreover, the PAT numbers saw an up movement from Rs 152 crores to Rs 217 crores exhibiting an increase of around 42 percent.
The profitability ratios of the company such as the return on equity (ROE) as well as the return on capital employed (ROCE) have increased in recent financial years. ROE increased from 6.58 percent during FY20-21 to 9.2 percent in FY21-22. Moreover, ROCE took a shift from 10 percent to 11.24 percent during that similar period.
Anupam Rasayan India Limited is engaged in the manufacturing and custom synthesis of specialty chemicals in India. Business verticals of the company mainly include life science-related specialty chemicals comprising products related to personal care, pharmaceuticals, agrochemicals, and other specialty chemicals.
Written by Amit Madnani
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
